Submitted by Anonymous (not verified) on 13 November 2023 - 16:18
Human medicines European public assessment report (EPAR): Simponi, golimumab, Arthritis, Psoriatic;Spondylitis, Ankylosing;Colitis, Ulcerative;Arthritis, Rheumatoid, Date of authorisation: 01/10/2009, Revision: 48, Status: Authorised
Source: